Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.

Dajani R, Fatahallah R, Dajani A, Al-Shboul M, Khader Y.

Mol Biol Rep. 2012 Sep;39(9):9133-8. doi: 10.1007/s11033-012-1785-7. Epub 2012 Jun 29.

PMID:
22744422
2.

Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.

Nusier MK, Radaideh AM, Ababneh NA, Qaqish BM, Alzoubi R, Khader Y, Mersa JY, Irshaid NM, El-Khateeb M.

Neuro Endocrinol Lett. 2007 Oct;28(5):699-703.

PMID:
17984931
3.

Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.

Rahimi Z, Vaisi-Raygani A, Mozafari H, Kharrazi H, Rezaei M, Nagel RL.

J Thromb Thrombolysis. 2008 Jun;25(3):280-3. Epub 2007 Aug 14.

PMID:
17700999
4.

Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.

Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T.

J Thromb Thrombolysis. 2005 Dec;20(3):163-8.

PMID:
16261289
5.
6.

Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan.

Dajani R, Arafat A, Hakooz N, Al-Abbadi Z, Yousef AM, El Khateeb M, Quadan F.

J Thromb Thrombolysis. 2013 Jan;35(1):83-9. doi: 10.1007/s11239-012-0772-0.

PMID:
23011539
7.

Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.

Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, Busabaratana M, Sura T, Atichartakarn V, Sritara P.

Am J Hematol. 2000 Oct;65(2):119-22.

PMID:
10996828
8.

Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.

Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY.

Am J Hematol. 2002 Dec;71(4):300-5.

9.

Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.

Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L; FITENAT Study Group.

Blood Coagul Fibrinolysis. 2009 Oct;20(7):503-10. doi: 10.1097/MBC.0b013e32832f5d7a.

PMID:
19730248
10.
11.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
12.

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.

J Thromb Thrombolysis. 2005 Jun;19(3):189-96.

PMID:
16082606
13.

[Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain].

Francès F, Portolès O, Gabriel F, Corella D, Sorlí JV, Sabater A, Alfonso JL, Guillén M.

Rev Med Chil. 2006 Jan;134(1):13-20. Epub 2006 Mar 8. Spanish.

14.

Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.

Rahimi Z, Ghaderi M, Nagel RL, Muniz A.

J Thromb Thrombolysis. 2008 Dec;26(3):229-33. Epub 2007 Nov 4.

PMID:
17982733
15.

The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.

Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M.

Blood Coagul Fibrinolysis. 2009 Dec;20(8):675-8. doi: 10.1097/MBC.0b013e3283315b4f.

PMID:
19710606
16.

The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia.

Bôžiková A, Gabriková D, Sovičová A, Behulová R, Mačeková S, Boroňová I, Petrejčíková E, Soták M, Bernasovská J, Bernasovský I.

J Thromb Thrombolysis. 2012 Oct;34(3):406-9.

PMID:
22562116
17.

Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.

Thromb Haemost. 2001 Sep;86(3):809-16. Erratum in: Thromb Haemost 2001 Dec;86(6):1598.

PMID:
11583312
18.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

19.

Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.

Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Ciccia F, Ghirarduzzi A, Filippini D, Paolazzi G, Iori I.

Arthritis Rheum. 2004 Apr 15;51(2):177-83.

20.

Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.

Bagheri M, Rad IA, Nanbakhsh F.

Arch Gynecol Obstet. 2011 Nov;284(5):1311-5. doi: 10.1007/s00404-011-2008-5. Epub 2011 Jul 20.

PMID:
21773779

Supplemental Content

Support Center